FEATURED ARTICLES
The Holistic Guide To Supply Chain For Cell & Gene Therapy Startups
How does the cell and gene therapy supply chain team stay ahead of the expected changes and respond at the speed the developing program expects? Supplier selection, raw materials, built-in quality, warehousing and logistics, and traceability are all covered in this article.
-
![supply chain 2 (002)]( "Cell & Gene Therapies Require the Right Tracking Solution")
Cell & Gene Therapies Require the Right Tracking SolutionIn cell therapy trials, the ability to track a patient’s cells is essential. When you have over 100 patients, and the cells will require multiple shipments, using a spreadsheet is not possible. “For the safety of our patient, accurate tracking is a must,” says Gerald Garrett, VP of clinical operations for MarkerTherapeutics. “We need to know exactly where the product is at any step of the way.”
-
10 Things To Remember About The QP Role And Process
The QP process is a necessary process that every sponsor company wishing to undertake trials in, or move product through the European Union must undergo. When faced with this process, many companies are unsure as to what to expect.
-
![clinical news]( "Clinical News Roundup: Should Cancer Patients Find Their Own Trials?")
Clinical News Roundup: Should Cancer Patients Find Their Own Trials?Clinical News Roundup for the week of May 29, 2017 with information on cancer patients finding their own trials, Marken launching a new hybrid clinical trial service, a call for clinical trial overhaul, and Califf making a new start with Verily.
